Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rocket Pharmaceuticals (RCKT)
NASDAQ:RCKT
Holding RCKT?
Track your performance easily
Rocket Pharmaceuticals (RCKT) Ownership Overview
17.93% Insiders
23.14% Mutual Funds
40.30% Other Institutional Investors
11.15% ETFs
7.48% Public Companies and Individual Investors
The ownership structure of Rocket Pharmaceuticals (RCKT) stock is a mix of institutional, retail, and individual investors. Approximately 74.59% of the company’s stock is owned by Institutional Investors, 17.93% is owned by Insiders, and 7.48% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 25, 2024 | Gaurav Shah Ceo,director | xxxxxxxxxxxxx | $144738 |
| Nov 25, 2024 | John Militello Vp Of Finance, Treasurer, Principal Accounting Officer | xxxxxxxxxxxxx | $15973 |
| Nov 25, 2024 | Kinnari Patel President, Head Of R&d And Coo | xxxxxxxxxxxxx | $59873 |
| Nov 25, 2024 | xxxxxxxxxxxxx | $15334 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $11101633 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $17211287 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $76071871 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,272,635 | Insider | 15.59% | 195,597,073 | |
| 6,490,225 | Institution | 6.22% | 78,012,505 | |
| 5,258,808 | Institution | 5.04% | 63,210,872 | |
| 4,622,076 | Institution | 4.43% | 55,557,354 | |
| 4,118,672 | Institution | 3.95% | 49,506,437 | |
| 3,494,393 | Institution | 3.35% | 42,002,604 | |
| 1,521,642 | Institution | 1.46% | 18,290,137 | |
| 1,113,566 | Insider | 1.07% | 13,385,063 | |
| 1,053,860 | Institution | 1.01% | 12,667,397 | |
| 1,008,397 | Institution | 0.97% | 12,120,932 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,490,225 | Institution | 6.22% | 78,012,505 | |
| 4,622,076 | Institution | 4.43% | 55,557,354 | |
| 1,053,860 | Institution | 1.01% | 12,667,397 | |
| 1,008,397 | Institution | 0.97% | 12,120,932 | |
| 989,051 | Institution | 0.95% | 11,888,393 | |
| 770,691 | Institution | 0.74% | 9,263,706 | |
| 762,367 | Institution | 0.73% | 9,163,651 | |
| 736,820 | Institution | 0.71% | 8,856,576 | |
| 690,270 | Institution | 0.66% | 8,297,045 | |
| 580,600 | Institution | 0.56% | 6,978,812 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,217,961 | Institution | 2.13% | 36,929,051 | |
| 1,902,374 | Institution | 1.82% | 22,866,535 | |
| 1,077,655 | Institution | 1.03% | 17,942,956 | |
| 1,299,269 | Institution | 1.25% | 16,331,811 | |
| 856,799 | Institution | 0.82% | 14,265,703 | |
| 471,301 | Institution | 0.45% | 7,847,162 | |
| 595,285 | Institution | 0.57% | 7,155,326 | |
| 569,248 | Institution | 0.55% | 6,842,361 | |
| 299,804 | Institution | 0.29% | 4,991,737 | |
| 342,110 | Institution | 0.33% | 4,300,323 |
FAQ
Who Owns Rocket Pharmaceuticals (RCKT)?
According to the latest TipRanks data, approximately 40.30% of the company's stock is held by institutional investors, 17.93% is held by insiders, and 7.48% is held by retail investors.
What percentage of Rocket Pharmaceuticals (RCKT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 40.30% of Rocket Pharmaceuticals (RCKT) stock is held by institutional investors.
What percentage of Rocket Pharmaceuticals (RCKT) stock is held by retail investors?
According to the latest TipRanks data, approximately 7.48% of Rocket Pharmaceuticals (RCKT) stock is held by retail investors.
Who owns the most shares of Rocket Pharmaceuticals (RCKT)?
RODERICK WONG owns the most shares of Rocket Pharmaceuticals (RCKT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.